focus -WSS

focus

author：entertainment 2025-10-01 04:12:11 - browse：1

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Biden administration sends mixed signals on US soldier who crossed into North Korea

WSS

Medicare Advantage enrollment hits roughly 33.4 million

Secretariat’s lessons for human medicine

A look at other Americans who have crossed into North Korea over the years

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

entertainment

focus

hotspot

Medicare details structure of new drug price negotiation program

A new drug could help frostbite victims avoid its ravages

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Lack of darker skin in textbooks, journals harms patients of color

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Supreme Court strikes down use of affirmative action

FDA warns medical device makers about rise in fabricated data

How one medical school became remarkably diverse

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

focus

WATCH: Why do our ears pop?

Surprise medical billing ban raises prices elsewhere

FDA seeking to stop procedures at two unregulated stem cell clinics

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Manchin plays down potential 3rd

leisure time

hotspot

entertainment

Wikipedia